ArticleInternational journal of clinical oncology2023

Morphological response and tumor shrinkage as predictive factors in metastatic colorectal cancer treated with first-line capecitabine, oxaliplatin, and bevacizumab.

Tomoyuki Nagaoka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.